
Press Room
Resources dedicated to journalists and media professionals
The PR department responds to all media requests for information on scientific, medical, technological and entrepreneurial activities at Paris Brain Institute.
It disseminates new results from research teams and connects journalists to a relevant expert to comment on a current issue.
Feel free to contact our press officer to help you develop a topic that relies on state-of-the-art knowledge in neuroscience, neurology or psychiatry.
Press contact
Marie Simon
Email
:
presse@icm-institute.org
Our press documents

Researchers led by Emmanuel Flamand-Roze, at Paris Brain Institute, have shown that a simple administration of oxygen can alleviate abnormal movement attacks in an orphan disease – alternating hemiplegia of childhood (AHC). These encouraging...
02.21.2023
Research, science & health

Sensory neurons pick up information from our senses and relay it to the rest of the nervous system. But this is not their only mission. In a new study published in the journal Current Biology, Claire Wyart at Paris Brain Institute, and Christina...
02.20.2023
Research, science & health

The European Research Council (ERC) has just published the list of the winners of the grants it is about to distribute. This year, two researchers from at the Paris Brain Institute have been distinguished.
02.07.2023
Research, science & health

The acquisition of reading and writing are complex mechanisms whose subtleties we do not yet understand. Fabien Hauw and Laurent Cohen (Inserm, CNRS, Sorbonne University, AP-HP), neurologists at Paris Brain Institute, hope to uncover how we connect...
02.03.2023
Research, science & health

Disinhibition is one of the main symptoms of the behavioural variant frontotemporal dementia (bvFTD), a type of dementia associated with degeneration of the frontal and temporal lobes of the brain. Patients with bvFTD exhibit behaviours that are...
01.30.2023
Research, science & health

The work of Professor Fanny Mochel (AP-HP, Sorbonne University) at Paris Brain Institute, in collaboration with clinical research teams in eight countries and Spanish biotech Minoryx Therapeutics, has demonstrated the protective effects of...
01.20.2023
Research, science & health

Researchers from Inserm, CNRS, Sorbonne University and clinicians from the AP-HP and at Paris Brain Institute identified one of the mechanisms explaining ketamine effect as an antidepressant. Ketamine, usually used as an anesthetic, was administered...
10.06.2022
Research, science & health
Our useful documents
All
No results found
News that might interest you